Matthew R Plooster - Net Worth and Insider Trading
Matthew R Plooster Net Worth
The estimated net worth of Matthew R Plooster is at least $7,445 dollars as of 2024-06-10. Matthew R Plooster is the Director of Zevra Therapeutics Inc and owns about 1,601 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $7,445. Details can be seen in Matthew R Plooster's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew R Plooster has not made any transactions after 2023-03-09 and currently still holds the listed stock(s).
Transaction Summary of Matthew R Plooster
Matthew R Plooster Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew R Plooster owns 1 companies in total, including Zevra Therapeutics Inc (ZVRA) .
Click here to see the complete history of Matthew R Plooster’s form 4 insider trades.
Insider Ownership Summary of Matthew R Plooster
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2023-03-09 | director |
Matthew R Plooster Latest Holdings Summary
Matthew R Plooster currently owns a total of 1 stock. Matthew R Plooster owns 1,601 shares of Zevra Therapeutics Inc (ZVRA) as of March 9, 2023, with a value of $7,445.
Latest Holdings of Matthew R Plooster
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2023-03-09 | 1,601 | 4.65 | 7,445 |
Holding Weightings of Matthew R Plooster
Matthew R Plooster Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew R Plooster has made a total of 2 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 11,000 shares on March 9, 2023, which cost Matthew R Plooster around $46,200.
Insider Trading History of Matthew R Plooster
- 1
Matthew R Plooster Trading Performance
GuruFocus tracks the stock performance after each of Matthew R Plooster's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew R Plooster is 23.98%. GuruFocus also compares Matthew R Plooster's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew R Plooster within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew R Plooster's insider trading performs compared to the benchmark.
Performance of Matthew R Plooster
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.07 | | | | | |
| Relative Return to S&P 500(%) | 11.86 | | | | | |
Matthew R Plooster Ownership Network
Matthew R Plooster Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
Matthew R Plooster is the director of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include director & President and CEO Neil F. Mcfarlane , VP Fin & Corp Controller R. Laduane Clifton , and CCO & EVP & Bus. Development Joshua Schafer .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, Matthew R Plooster made 1 insider transaction in Zevra Therapeutics Inc (ZVRA) with a net purchase of 11,000. Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 6,100 shares made by R. Laduane Clifton , a net purchase of 3,500 shares made by Joshua Schafer , and a net purchase of 1,000 shares made by Watton Corey Michael .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 77,819 shares were bought by its insiders, resulting in a net purchase of 77,819 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
Matthew R Plooster Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew R Plooster. You might contact Matthew R Plooster via mailing address: 2656 Crosspark Road, Suite 100, Coralville Ia 52241.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
